| OCC | LCC | NIR-CC | P value |
---|---|---|---|---|
Patients | 56 | 110 | 21 | Â |
Age (year) | 69 (33–95) | 68 (24–98) | 70.8 (46–92) | 0.774 |
Gender | ||||
 Female (%) | 25 (44.6%) | 52 (47.3%) | 7 (33%) | 0.36 |
 Male (%) | 31 (55.4%) | 58 (52.7%) | 14 (67%) |  |
 BMI(kg/m2) | 24.13 (17.2–34.9) | 24.27 (13.6–40.4) | 25.17 (16.1–34.7) | 0.41 |
 CRP(mg/L) | 33.7 (0.5–380) | 37.2 (0.2–359) | 16.4 (0.4–57.4) | 0.548 |
 Alkaline Phosphatase (U/L) | 188.8 (52–742) | 160.4 (38–677) | 196.5 (51–693) | 0.349 |
 WBC(1000/μL) | 7.5 (3.4–25) | 7.4 (3–19.8) | 6.43 (3.9–12.6) | 0.471 |
 Bilirubin T (mg/dL) | 1.77 (0.2–15.3) | 1.61 (0.2–13.8) | 1.77 (0.3–8.8) | 0.859 |
Preoperative drainage | ||||
 ERBD (%) | 19 (33.9%) | 52 (47.3%) | 11 (52.4%) | 0.216 |
 PTCD (%) | 4 (7.1%) | 4 (3.6%) | 4 (19%) | 0.041 |
 PTGBD (%) | 7 (12.5%) | 18 (16.4%) | 6 (28.6%) | 0.195 |
 T tube placement (%) | 40 (71.4%) | 47 (42.7%) | 17 (81%) | 0.043 |
 Abdominal surgical history (%) | 32 (57.1%) | 13 (11.8%) | 10 (47%) | 0.0001 |
 Operative time(minutes) | 181 (74–450) | 237 (108–580) | 289 (163–454) | 0.0001 |
 Conversion (%)* | - | 17 (15.5%) | 4 (19%) | 0.746* |
 Major complications (%) | 0 (0%) | 3 (2.7%) | 0 (0%) | 0.404 |
 Minor complications (%) | 8 (14.3%) | 21 (19.1%) | 5 (24%) | 0.948 |
 PHOS (days) | 16 (3–179) | 8 (2–64) | 12.8 (3–16) | 0.0001 |